These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28601365)

  • 1. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine.
    Zhang F; Jun M; Ledue O; Herd M; Malley R; Lu YJ
    Vaccine; 2017 Jul; 35(31):3834-3843. PubMed ID: 28601365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of phytol-derived diterpenoid immunoadjuvants over alum in shaping the murine host's immune response to Staphylococcus aureus.
    Roy Chowdhury R; Fitch RW; Ghosh SK
    Vaccine; 2013 Feb; 31(8):1178-86. PubMed ID: 23313815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    Mancini F; Monaci E; Lofano G; Torre A; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Galletti B; Laera D; Pallaoro M; Tuscano G; Fontana MR; Bensi G; Grandi G; Rossi-Paccani S; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Soldaini E; Bertholet S
    PLoS One; 2016; 11(1):e0147767. PubMed ID: 26812180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Moscoso M; García P; Cabral MP; Rumbo C; Bou G
    Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of antibodies generated in heifers through immunization with Staphylococcus aureus vaccines in invasion and phagocytosis assays.
    Renna MS; Pereyra EA; Baravalle C; Camussone CM; Dallard BE; Marcipar IS; Calvinho LF
    FEMS Microbiol Lett; 2014 Nov; 360(1):62-9. PubMed ID: 25155690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by
    Karauzum H; Venkatasubramaniam A; Adhikari RP; Kort T; Holtsberg FW; Mukherjee I; Mednikov M; Ortines R; Nguyen NTQ; Doan TMN; Diep BA; Lee JC; Aman MJ
    Front Immunol; 2021; 12():624310. PubMed ID: 33777005
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice.
    Xu H; Hu C; Gong R; Chen Y; Ren N; Xiao G; Xie Q; Zhang M; Liu Q; Guo A; Chen H
    Clin Vaccine Immunol; 2011 Jun; 18(6):893-900. PubMed ID: 21508165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
    Creech CB; Frenck RW; Sheldon EA; Seiden DJ; Kankam MK; Zito ET; Girgenti D; Severs JM; Immermann FW; McNeil LK; Cooper D; Jansen KU; Gruber W; Eiden J; Anderson AS; Baber J
    Vaccine; 2017 Jan; 35(2):385-394. PubMed ID: 27866765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.
    Joshi A; Pancari G; Cope L; Bowman EP; Cua D; Proctor RA; McNeely T
    Hum Vaccin Immunother; 2012 Mar; 8(3):336-46. PubMed ID: 22327491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
    Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
    Mocca CP; Brady RA; Burns DL
    Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP; Thompson CD; Aman MJ; Lee JC
    Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.